Kala Bio (Kala Pharmaceuticals, Inc.) is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for eye diseases. Their primary strategy involves leveraging their proprietary AMPPLIFY® drug delivery technology to address unmet medical needs in ophthalmology. The company does not publicly disclose any investment preferences or activities within the infrastructure industry.